Work

Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases

Year: 2019

Type: article

Study design: Observational Study

Source: Digestive Diseases and Sciences

DOI: 10.1007/s10620-019-05570-1

Authors: Andres J. Yarur, Alexandra Bruss, Snehal Naik, Poonam Beniwal-Patel, Caroline Fox, Anjali Jain, Brandon Berens, Amir Patel, Ryan Ungaro, Bayda Bahur, Marla Dubinsky, Daniel J. Stein

Institutions: Medical College of Wisconsin, Prometheus Biosciences (United States), Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Prometheus, Crohn's and Colitis Foundation, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease, G7333137526, Clinical and Translational Science Award

OpenAlex ID: W2919105977

FWCI: 3.905

Cites: 19

Cited by: 49

Related to: 10